(Q37677185)

21 August 2017

1 reference

title

Emergencies in parkinsonism: akinetic crisis, life-threatening dyskinesias, and polyneuropathy during L-Dopa gel treatment (English)

1 reference

21 August 2017

1 reference

1 reference

parkinsonian syndrome

1 reference

Laura Bonanni

2

0 references

Astrid Thomas

Astrid Thomas

6

0 references

Marco Onofrj

Marco Onofrj

1

0 references

Fabrizio Stocchi

Fabrizio Stocchi

5

0 references

Giovanni Cossu

3

Giovanni Cossu

1 reference

21 August 2017

Davide Manca

4

1 reference

21 August 2017

language of work or name

1 reference

1 December 2009

1 reference

Parkinsonism and Related Disorders

21 August 2017

published in

1 reference

21 August 2017

volume

15 Suppl 3

1 reference

21 August 2017

page(s)

S233-6

1 reference

Movement disorder emergencies.

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970821-1

7 January 2021

Movement disorder emergencies

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970821-1

7 January 2021

Acute akinesia in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970821-1

7 January 2021

Neuroleptic malignant syndrome or parkinsonism hyperpyrexia syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970821-1

7 January 2021

Parkinsonism-hyperpyrexia syndrome: the role of electroconvulsive therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970821-1

7 January 2021

A collaborative study on the malignant syndrome in Parkinson's disease and related disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970821-1

7 January 2021

Acute Akinesia, an unusual complication in Parkinson's Disease: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970821-1

7 January 2021

Akinetic crisis caused by rectus sheath hematoma and acute anemia due to subcutaneous administration of apomorphine

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970821-1

7 January 2021

Classification of fluctuations in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970821-1

7 January 2021

Successful treatment of an episode of malignant hyperthermia using a large dose of dantrolene

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970821-1

7 January 2021

RETRACTED: Efficacy of methylprednisolone pulse therapy on neuroleptic malignant syndrome in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970821-1

7 January 2021

Treatment of neuroleptic malignant syndrome with subcutaneous apomorphine monotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970821-1

7 January 2021

Dementia with Lewy bodies and Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970821-1

7 January 2021

Malignant hyperthermia: excitation-contraction coupling, Ca2+ release channel, and cell Ca2+ regulation defects

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970821-1

7 January 2021

Identification of a dantrolene-binding sequence on the skeletal muscle ryanodine receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970821-1

7 January 2021

[Acute akinesia in a patient with Parkinson disease]

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970821-1

7 January 2021

Transdermal dopaminergic stimulation with rotigotine in Parkinsonian akinetic crisis

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970821-1

7 January 2021

Presynaptic mechanisms of motor fluctuations in Parkinson's disease: a probabilistic model

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970821-1

7 January 2021

Dyskinesia after fetal cell transplantation for parkinsonism: a PET study

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970821-1

7 January 2021

A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970821-1

7 January 2021

Dyskinesias following neural transplantation in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970821-1

7 January 2021

Transplantation of embryonic dopamine neurons for severe Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970821-1

7 January 2021

Factors affecting the clinical outcome after neural transplantation in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970821-1

7 January 2021

Stiff person syndrome with eye movement abnormality, myasthenia gravis, and thymoma

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970821-1

7 January 2021

Neuropathy as a potential complication of levodopa use in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970821-1

7 January 2021

Duodenal levodopa infusion for advanced Parkinson's disease: 12-month treatment outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970821-1

7 January 2021

Homocysteine and levodopa: should Parkinson disease patients receive preventative therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970821-1

7 January 2021

Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970821-1

7 January 2021

Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970821-1

7 January 2021

Reversible encephalopathy and axonal neuropathy in Parkinson's disease during duodopa therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970821-1

7 January 2021

Neurologic degeneration associated with nitrous oxide anesthesia in patients with vitamin B12 deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970821-1

7 January 2021

Levodopa-associated increase of homocysteine levels and sural axonal neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970821-1

7 January 2021

10.1016/S1353-8020(09)70821-1

Identifiers

DOI

1 reference

21 August 2017

1 reference